Central Garden & Pet Co: Form 10-Q for the period ended Mar 27, 2021
Filed with the SEC on May 6, 2021 and accepted by EDGAR at May 6, 2021, 13:58 ET.
Management's discussion and analysis
As filed, 63,680 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our Company
Central Garden & Pet Company (“Central”) is a leading innovator, producer and distributor of branded and private label products for the lawn & garden and pet supplies markets in the United States. We have grown our business through a succession of over 50 acquisitions and created a broad portfolio which allows for economies of scale and market advantages.
Our pet supplies include products for dogs and cats like premium edible chews and treats, dog chew toys, dog play toys, natural dog treats and chews, pet dental chews and solutions, pet beds, dog training pads, pet containment, grooming supplies and other accessories;
products for birds, small animals and specialty pets, including food, cages and habitats, toys, chews and related accessories; animal and household health and insect control products; live fish and products for fish, reptiles and other aquarium-based pets, including aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food and supplements, products for horses and livestock, as well as outdoor cushions and pillows. These products are sold under the brands including Aqueon®, Cadet®, Comfort Zone®, Farnam®, Four Paws®, Kaytee®, K&H Pet Products®, Nylabone®, and Zilla® as well as a number of other brands including Adams™, Altosid®, Arden Companies™, Coralife®, C&S Products®, Interpet®, Pet Select®, TFH™, and Zodiac®.
Our lawn and garden supplies products include proprietary and non-proprietary grass seed; wild bird feed, bird feeders, bird houses and other birding accessories; seed packets and seed starter products, weed, grass, and other herbicides, insecticide and pesticide products; fertilizers; and decorative outdoor lifestyle products including pottery, as well as live plants. These products are sold under the brands AMDRO®, Pennington®, and Sevin®, as well as a number of other brand names including Bell Nursery, Ironite®, Ferry-Morse®, Lilly Miller® and Over-N-Out®.
In fiscal 2020, our consolidated net sales were $2.7 billion, of which our Pet segment, or Pet, accounted for approximately $1.6 billion and our Garden segment, or Garden, accounted for approximately $1.1 billion. In fiscal 2020, our operating income was $198 million consisting of income from our Pet segment of $154 million, income from our Garden segment of $133 million and corporate expenses of $89 million.
We were incorporated in Delaware in May 1992 as the successor to a California corporation that was formed in 1955. Our executive offices are located at 1340 Treat Boulevard, Suite 600, Walnut Creek, California 94597, and our telephone number is (925) 948-4000. Our website is www.central.com (http://www.central.com). The information on our website is not incorporated by reference in this quarterly report.
Recent Developments
Fiscal 2021 Second Quarter Financial Performance:
- Net sales increased $232.1 million, or 33.0%, from the prior year quarter to $935.3 million due to an increase in organic sales and recent acquisitions. Pet segment sales increased $86.5 million, and Garden segment sales increased $145.6 million.
- Organic net sales increased 23.2%, comprised of 23.1% in our Pet segment and 23.3% in our Garden segment.
- Gross profit increased $65.3 million from the prior year quarter, and gross margin decreased 40 basis points to 29.1%.
- Selling, general and administrative expense increased $26.8 million from the prior year quarter to $167.8 million, but declined as a percentage of net sales 220 basis points to 17.9%.
- Operating income increased $38.5 million, or 58.2%, from the prior year quarter, to $104.6 million.
- Net income in the second quarter of fiscal 2021 was $73.0 million, or $1.32 per diluted share, compared to a net income of $42.7 million, or $0.78 per diluted share, in the second quarter of fiscal 2020.
Acquisitions
On December 31, 2020, we purchased substantially all of the assets of Hopewell Nursery, a leading live goods wholesale grower serving garden centers, retail nurseries, landscape contractors and wholesalers across the Northeast, for approximately $81 million. The addition of Hopewell to the Central portfolio strengthens our position as a leading live goods provider in the garden segment.
On February 11, 2021, we acquired Flora Parent, Inc. and its subsidiaries ("Green Garden Products"), a leading provider of vegetable, herb and flower seed packets, seed starters and plant nutrients in North America, for approximately $571 million. We borrowed approximately $180 million on our credit facility to partially finance the acquisition. The addition of Green Garden Products is intended to expand our garden portfolio into an adjacent category.
Change in Segment Components
During the first quarter of fiscal year 2021, we began reporting the results of our outdoor cushion operations in the Pet segment as a result of a change in internal management reporting lines due to potential synergies in sourcing, manufacturing and innovation and to be consistent with the reporting of financial information used to assess performance and allocate resources. These operations were previously reported in the Garden segment and are now managed and reported in the Pet segment. All prior period segment disclosures have been recast to reflect this segment change.
COVID-19 Impact
The outbreak of COVID-19 has led to adverse impacts on human health, the global economy and society at large. The impact of COVID-19 and measures to prevent its spread are affecting our business in a number of ways. Central is considered an essential business in most jurisdictions and our employees continue to work to meet essential needs. From the beginning, our priority has been the safety of our employees, customers and consumers.
Central has been impacted by COVID-19 in a number of ways, including increased demand evidenced by our organic net sales increase of 23.2% for the six months ended March 27, 2021. The increased demand for our products continues to challenge our supply chain and our ability to procure and manufacture enough product to meet the continued high levels of demand.
Our facilities have largely been exempt or partially exempt from government closure orders. We have experienced temporary closures of certain facilities, though there has not been a material impact from a plant closure to date. At some of our facilities, we have experienced reduced productivity and increased employee absences, which we expect to continue during the current pandemic. Our manufacturing facilities and distribution centers are currently open and fully operational. We have incurred and will continue to incur additional costs including personal protective equipment and sanitation costs. We have hosted mobile vaccination clinics at some of our larger manufacturing and distribution sites, providing vaccines to our employees.
The pandemic and related increase in demand have created operational challenges which have impacted our service and fill rates. In our supply chain, we may continue to experience increased operational and logistics costs, although these did not have a material impact on our second fiscal quarter results. We may also experience additional disruptions in our supply chain as the pandemic continues, although we cannot reasonably estimate the potential impact or timing of those events, and we may not be able to mitigate such impact.
We believe we have sufficient liquidity to satisfy our cash needs with our cash and revolving credit facility as we manage through the current economic and health environment.
The volatility in demand, changing consumer consumption patterns, uncertainty regarding vaccination efforts and new variants of the virus make it difficult to predict when more normal order patterns may return. Forecasting and planning remain challenging in the current environment and will continue to be challenging as the pandemic eases in the future. In the current uncertain environment, our employees, customers and consumers will continue to be our priority as we manage our business to deliver long-term growth.
Subsequent Events
In April 2021, we issued $400 million aggregate principal amount of 4.125% senior notes due April 2031 (the “Notes”). We used a portion of the net proceeds to repay outstanding amounts under our senior secured revolving credit facility, with the remainder available for general corporate purposes. The Notes were issued in a private placement under Rule 144A and will not be registered under the Securities Act of 1933.
Results of Operations
Three Months Ended March 27, 2021
Compared with Three Months Ended March 28, 2020
Net Sales
Net sales for the three months ended March 27, 2021 increased $232.1 million, or 33.0%, to $935.3 million from $703.2 million for the three months ended March 28, 2020. Organic net sales, which exclude the impact of acquisitions and divestitures in the last 12 months, increased $161.9 million, or 23.2%, as compared to the fiscal 2020 quarter. Our branded product sales increased $181.1 million, and sales of other manufacturers’ products increased $51.0 million.
Pet net sales increased $86.5 million, or 21.3%, to $492.0 million for the three months ended March 27, 2021 from $405.5 million for the three months ended March 28, 2020. Net sales in the prior year quarter included sales from the Breeder’s Choice business unit which we sold in December 2020. Organic net sales increased $92.4 million, or 23.1%, as compared to the prior year quarter. The sales increase was broad-based across our entire Pet portfolio and we continue to see increased demand during the pandemic due, among other things, to increased pet ownership in dog, cat, small animals and reptiles. Organic sales gains were most significant in our dog and cat, third-party product and wild bird feed businesses. Pet branded product sales increased $75.3 million, and sales of other manufacturers' products increased $11.2 million.
Garden net sales increased $145.6 million, or 48.9%, to $443.3 million for the three months ended March 27, 2021 from $297.7 million for the three months ended March 28, 2020. Sales from our recent acquisitions of DoMyOwn, Hopewell and Green Garden Products were $76.1 million and organic net sales increased $69.5 million, or 23.3%. The increased sales were broad-based across our entire Garden portfolio, including increases in sales of other manufacturers’ products and controls and fertilizers. The increased demand and sales of our products are believed to be due in significant part to increased consumer home gardening related to the pandemic and listing gains. Garden branded sales increased $105.8 million, and sales of other manufacturers' products increased $39.8 million.
Gross Profit
Gross profit for the three months ended March 27, 2021 increased $65.3 million, or 31.5%, to $272.4 million from $207.1 million for the three months ended March 28, 2020. Gross margin decreased 40 basis points to 29.1% for the three months ended March 27, 2021 from 29.5% for the three months ended March 28, 2020. Gross profit increased in both operating segments. The consolidated gross margin decline was due primarily to the initial inventory-related purchase accounting adjustments related to the three recent acquisitions in our Garden segment, although a small decline in the Pet Segment gross margin was also a contributing factor.
In the Pet segment, gross profit increased across the portfolio, with particular strength in our dog & cat business. The Pet segment gross margin declined due primarily to cost inflation (e.g., in commodities in our bird feed business, labor and ocean freight) more than offsetting gains from volume-related efficiencies.
In the Garden segment, gross profit increased from both organic and acquired businesses while the gross margin remained relatively stable as compared to the prior year quarter. Gains from the net sales increase and leveraging fixed costs were offset by cost inflation in commodities, labor and freight. Additionally, the three recent acquisitions in our Garden segment had a negative impact on the Garden gross margin due to the impact of our initial inventory-related purchase accounting adjustments.
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased $26.8 million, or 19.0%, to $167.8 million for the three months ended March 27, 2021 from $141.0 million for the three months ended March 28, 2020. Selling, general and administrative expense increased in both operating segments and in corporate. As a percentage of net sales, selling, general and administrative expenses decreased to 17.9% for the three months ended March 27, 2021, compared to 20.1% in the comparable prior year quarter impacted by improved operating leverage and reduced travel and entertainment expense.
Selling and delivery expense increased to $83.1 million for the three months ended March 27, 2021 as compared to $71.8 million in the prior year quarter. The increase was due primarily to increased delivery expense, as a result of increased sales volumes, increased payroll-related costs and the selling and delivery expenses from our three recent acquisitions in our Garden Segment. These increases were partially offset by reduced travel and entertainment expense due to COVID-19 safety measures reducing our in-store merchandising presence and travel in general.
Warehouse and administrative expense increased $15.5 million, or 22.3%, to $84.7 million for the three months ended March 27, 2021 from $69.2 million for the three months ended March 28, 2020. The increase was due primarily to the warehouse and administrative costs associated with our three recent acquisitions, including the amortization of intangibles related to purchase accounting. Additionally, both operating segments experienced increased labor and payroll-related expense. Corporate expenses increased $2.9 million due primarily to increased variable compensation, payroll expense and increased equity compensation expense. Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resources, and information technology functions.
Operating Income
Operating income increased $38.5 million, or 58.2%, to $104.6 million for the three months ended March 27, 2021. The increase in operating income was attributable to increased sales and gross profit partially offset by increased selling, general and administrative expense. Our operating margin increased from 9.4% in the prior year quarter to 11.2% in the current year quarter due to a 220 basis point decline in selling, general and administrative expense as a percentage of net sales, partially offset by a 40 basis point decline in gross margin.
Pet operating income increased $18.6 million, or 42.7%, to $62.1 million for the three months ended March 27, 2021 from $43.5 million for the three months ended March 28, 2020. Pet operating income increased due to increased sales and gross profit partially offset by higher selling, general and administrative expense. Pet operating margin improved 190 basis points due to increased sales and lower selling, general and administrative expense as a percentage of net sales, partially offset by a lower gross margin.
Garden operating income increased $22.8 million to $66.0 million for the three months ended March 27, 2021 from $43.2 million for the three months ended March 28, 2020. Garden operating income increased due to increased sales and gross profit partially offset by higher selling, general and administrative expense. Garden operating margin improved to 14.9% due to increased sales and lower selling, general and administrative expense as a percentage of net sales.
Corporate operating expense increased $2.9 million, or 14.0%, to $23.4 million for the three months ended March 27, 2021 from $20.5 million for the three months ended March 28, 2020. Corporate expense increased due primarily to increased variable compensation, payroll expense and increased equity compensation expense, but declined as a percentage of consolidated net sales.
Net Interest Expense
Net interest expense for the three months ended March 27, 2021 increased $0.9 million, or 8.7%, to $10.2 million from $9.3 million for the three months ended March 28, 2020 due primarily to higher debt balances outstanding during the quarter. Debt outstanding on March 27, 2021 was $979.0 million compared to $693.7 million at March 28, 2020.
Other Income (Expense)
Other income (expense) is comprised of income or losses from investments accounted for under the equity method of accounting and foreign currency exchange gains and losses. Other income was $0.7 million of income for the quarter ended March 27, 2021 compared to expense of $1.0 million for the quarter ended March 28, 2020, due primarily to foreign currency gains in the current year quarter as compared to losses in the prior year quarter.
Income Taxes
Our effective income tax rate was 22.7% for the quarter ended March 27, 2021 and for the quarter ended March 28, 2020.
Net Income and Earnings Per Share
Our net income in the second quarter of fiscal 2021 was $73.0 million, or $1.32 per diluted share, compared to a net income of $42.7 million, or $0.78 per diluted share, in the second quarter of fiscal 2020.
Six Months Ended March 27, 2021
Compared with Six Months Ended March 28, 2020
Net Sales
Net sales for the six months ended March 27, 2021 increased $341.4 million, or 28.8%, to $1,527.5 million from $1,186.1 million for the six months ended March 28, 2020. Organic net sales increased $272.8 million, or 23.2%, as compared to the prior year six-month period. Our branded product sales increased $262.5 million, and sales of other manufacturers’ products increased $78.9 million.
Pet net sales increased $156.3 million, or 20.2%, to $928.4 million for the six months ended March 27, 2021 from $772.1 million for the six months ended March 28, 2020. Net sales in the prior year period include sales from the Breeder’s Choice business unit which we sold in December 2020. Organic net sales increased $164.1 million, or 21.5%, as compared to the prior year six-month period. The sales increase was broad-based across our entire Pet portfolio and we continue to see increased demand during the pandemic due, among other things, to increased pet ownership in dog, cat, small animals and reptiles. Organic sales gains were most significant in our dog and cat, third-party product and wild bird feed businesses. Pet branded sales increased $131.3 million, and sales of other manufacturer's products increased $25.0 million.
Garden net sales increased $185.1 million, or 44.7%, to $599.1 million for the six months ended March 27, 2021 from $414.0 million for the six months ended March 28, 2020. Organic sales increased $108.7 million, or 26.3%, and sales from our recent acquisitions of DoMyOwn, Hopewell and Green Garden Products contributed $76.4 million. The increased sales were broad-based across our entire Garden portfolio, including sales increases in sales of other manufacturers’ products, controls and fertilizers, wild bird feed and grass seed. We believe the sales increase across our Garden portfolio was driven in significant part by consumer engagement related to home activities such as gardening and retailer listing gains. Garden branded sales increased $131.2 million, and sales of other manufacturers’ products increased $53.9 million.
Gross Profit
Gross profit for the six months ended March 27, 2021 increased $99.4 million, or 29.4%, to $437.8 million from $338.4 million for the six months ended March 28, 2020. Gross margin increased 20 basis points to 28.7% for the six months ended March 27, 2021 from 28.5% for the six months ended March 28, 2020. Both Garden and Pet contributed to the increase in gross profit while, the gross margin increase was due primarily to the improvement in the Garden segment gross margin.
In the Pet segment, gross profit increased due to increased sales while the gross margin remained unchanged. Gross margin gains were due primarily to volume-related efficiencies and increased pricing, which were offset by increased commodity costs in our wild bird feed business, increased ocean freight costs, which impacted our aquatics and dog bedding businesses, and increased labor costs.
In the Garden segment, both gross profit and gross margin increased. Increased sales and gross margin improvement drove the increase in gross profit. The Garden gross margin improved in most of the Garden business units due primarily to increased sales which leveraged fixed production costs. This impact was especially noteworthy in our live plant, grass seed and controls and fertilizer businesses. These gross margin gains were partially offset by a decline in gross margin in our wild bird feed business, which was adversely impacted by increased commodity costs, and the impact of purchase accounting related to our recent acquisitions.
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased $36.0 million, or 13.3%, to $306.2 million for the six months ended March 27, 2021 from $270.2 million for the six months ended March 28, 2020. As a percentage of net sales, selling, general and administrative expenses decreased to 20.0% for the six months ended March 27, 2021 from 22.8% for the comparable prior year six-month period; both operating segments and corporate contributed to the improvement.
Selling and delivery expense increased $15.1 million, or 11.2%, to $149.5 million for the six months ended March 27, 2021 from $134.4 million for the six months ended March 28, 2020. The increase was due primarily to the addition of our three recent acquisitions, increased delivery expense, as a result of increased sales volumes and higher shipping costs, and increased payroll-related costs. These increases were partially offset by reduced travel and entertainment expense.
Warehouse and administrative expense increased $20.9 million, or 15.4%, to $156.7 million for the six months ended March 27, 2021 from $135.8 million for the six months ended March 28, 2020. The increased expense was driven by the addition of our three recent acquisitions in the Garden segment and a $2.6 million loss in our Pet segment resulting from the sale of the Breeder’s Choice business in our fiscal first quarter. Additionally, both operating segments experienced increased labor and payroll-related expense. Corporate expenses increased $4.2 million due primarily to increased variable compensation, payroll expense and increased non-cash equity compensation expense. Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resources, and information technology functions.
Operating Income
Operating income increased $63.5 million to $131.7 million for the six months ended March 27, 2021 from $68.2 million for the six months ended March 28, 2020. Our operating margin increased to 8.6% for the six months ended March 27, 2021 from 5.7% for the six months ended March 28, 2020. Increased sales of $341.4 million and a 280 basis point decrease in selling, general and administrative expense as a percentage of net sales were partially offset by a 20 basis point decline in gross margin.
Pet operating income increased $33.4 million, or 46.2%, to $105.6 million for the six months ended March 27, 2021 from $72.2 million for the six months ended March 28, 2020. Pet operating income increased due to increased sales and gross profit partially offset by higher selling, general and administrative expense. Pet operating margin improved 200 basis points due to increased sales and lower selling, general and administrative expense as a percentage of net sales.
Garden operating income increased $34.3 million to $70.6 million for the six months ended March 27, 2021 from $36.3 million for the six months ended March 28, 2020. Garden operating income increased due to increased sales and gross profit partially offset by higher selling, general and administrative expense. Garden operating margin improved 300 basis points to 11.8% due to increased sales, an improved gross margin and lower selling, general and administrative expense as a percentage of net sales.
Corporate operating expense increased $4.2 million to $44.5 million in the current six-month period from $40.3 million in the comparable fiscal 2020 period due primarily to increased variable compensation, payroll expense and increased non-cash equity compensation expense.
Net Interest Expense
Net interest expense for the six months ended March 27, 2021 increased $12.9 million, or 72.0%, to $30.9 million from $18.0 million for the six months ended March 28, 2020. In October 2020, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030 and used the proceeds to redeem all of our outstanding aggregate principal amount 6.125% senior notes due 2023 with the remainder available for general corporate purposes. As a result of our redemption of the 2023 Notes, we recognized incremental interest expense of approximately $10.0 million in the fiscal 2021 quarter. Also contributing to the increase in net interest expense was a higher debt balance during the six-month period.
Debt outstanding on March 27, 2021 was $979.0 million compared to $693.7 million as of March 28, 2020. Our average borrowing rate for the six months ended March 27, 2021 decreased to 4.6% from 5.8% for the six months ended March 28, 2020.
Other Income
Other income (expense) was income of $1.5 million for the six-month period ended March 27, 2021 compared to an expense of $0.7 million for the six-month period ended March 28, 2020. The increase was due primarily to foreign currency gains in the current six-month period.
Income Taxes
Our effective income tax rate was 22.5% for the six-month period ended March 27, 2021 compared to 22.1% for the six-month period ended March 28, 2020. Due to the large increase in earnings for the six-month period ended March 27, 2021, permanent tax benefits had a smaller impact on our current year effective tax rate.
Net Income and Earnings Per Share
Our net income for the six months ended March 27, 2021 was $78.6 million, or $1.43 per diluted share, compared to $38.3 million, or $0.69 per diluted share, for the six months ended March 28, 2020.
Use of Non-GAAP Financial Measures
We report our financial results in accordance with accounting principles generally accepted in the United States (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including non-GAAP net income and diluted net income per share, adjusted EBITDA and organic sales. Management believes these non-GAAP financial measures that exclude the impact of specific items (described below) may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods.
Adjusted EBITDA is defined by us as income before income tax, net other expense, net interest expense and depreciation and amortization (or operating income plus depreciation and amortization expense). We present adjusted EBITDA because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluation. Adjusted EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP. We believe that adjusted EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results. Other companies may calculate adjusted EBITDA differently and it may not be comparable.
We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions.
The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. We believe that the non-GAAP financial measures provide useful information to investors and other users of our financial statements by allowing for greater transparency in the review of our financial and operating performance. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating our performance, and we believe these measures similarly may be useful to investors in evaluating our financial and operating performance and the trends in our business from management's point of view. While our management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.
Non-GAAP financial measures reflect adjustments based on the following items:
- Incremental expenses from note redemption and issuance: we have excluded the impact of the incremental expenses incurred from the note redemption and issuance as they represent an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of these expenses supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.
- Loss on sale of business: we have excluded the impact of the loss on the sale of a business as it represents an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of this loss supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.
From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.
The non-GAAP adjustments reflect the following:
(1) During the first quarter of fiscal 2021, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030. We used the proceeds to redeem all of our outstanding 6.125% senior notes due 2023. As a result of our redemption of the 2023 Notes, we incurred incremental expenses of approximately $10.0 million, comprised of a call premium payment of $6.1 million, overlapping interest expense of approximately $1.4 million and a $2.5 million non-cash charge for the write-off of unamortized financing costs in interest expense. These amounts are included in Interest expense in the consolidated statements of operations.
(2) During the first quarter of fiscal 2021, we recognized a loss of $2.6 million, included in selling, general and administrative expense in the consolidated statement of operations, from the sale of our Breeder’s Choice business unit after concluding it was not a strategic business for our Pet segment.
(in thousands, except per share amounts)
| Net Income and Diluted Net Income Per Share Reconciliation | GAAP to Non-GAAP Reconciliation For the Six Months Ended March 27, 2021 | March 28, 2020 | |
|---|---|---|---|
| GAAP net income attributable to Central Garden & Pet Company | $78,567 | $38,287 | |
| Incremental expenses from note redemption and issuance | (1) | 9,952 | — |
| Loss on sale of business | (2) | 2,611 | — |
| Tax effect of incremental expenses and loss on sale | (2,821) | — | |
| Non-GAAP net income attributable to Central Garden & Pet | $88,309 | $38,287 | |
| GAAP diluted net income per share | $1.43 | $0.69 | |
| Non-GAAP diluted net income per share | $1.61 | $0.69 | |
| Shares used in GAAP and non-GAAP diluted net earnings per share calculation | 54,930 | 55,220 |
33
Organic Net Sales Reconciliation
We have provided organic net sales, a non-GAAP measure that excludes the impact of recent acquisitions and dispositions, because we believe it permits investors to better understand the performance of our historical business. We define organic net sales as net sales from our historical business derived by excluding the net sales from businesses acquired or exited in the preceding 12 months. After an acquired business has been part of our consolidated results for 12 months, the change in net sales thereafter is considered part of the increase or decrease in organic net sales.
(in millions)
| CONSOLIDATED | GAAP to Non-GAAP Reconciliation For Three Months Ended March 27, 2021 Net sales (GAAP) | Effect of acquisition & divestitures on increase in net sales | Net sales organic | For the Six Months Ended March 27, 2021 Net sales (GAAP) | Effect of acquisition & divestitures on increase in net sales | Net sales organic |
|---|---|---|---|---|---|---|
| Q2 FY 21 | $935.3 | $76.1 | $859.2 | $1,527.5 | $76.4 | $1,451.1 |
| Q2 FY 20 | $703.2 | $5.9 | $697.3 | $1,186.1 | $7.8 | $1,178.3 |
| $ increase | $232.1 | $161.9 | $341.4 | $272.8 | ||
| % increase | 33.0% | 23.2% | 28.8% | 23.2% |
(in millions)
| PET | GAAP to Non-GAAP Reconciliation For Three Months Ended March 27, 2021 Net sales (GAAP) | Effect of acquisition & divestitures on increase in net sales | Net sales organic | For the Six Months Ended March 27, 2021 Net sales (GAAP) | Effect of acquisition & divestitures on increase in net sales | Net sales organic |
|---|---|---|---|---|---|---|
| Q2 FY 21 | $492.0 | $— | $492.0 | $928.4 | $— | $928.4 |
| Q2 FY 20 | $405.5 | $5.9 | $399.6 | $772.1 | $7.8 | $764.3 |
| $ increase | $86.5 | $92.4 | $156.3 | $164.1 | ||
| % increase | 21.3% | 23.1% | 20.2% | 21.5% |
(in millions)
| GARDEN | GAAP to Non-GAAP Reconciliation For Three Months Ended March 27, 2021 Net sales (GAAP) | Effect of acquisition & divestitures on increase in net sales | Net sales organic | For the Six Months Ended March 27, 2021 Net sales (GAAP) | Effect of acquisition & divestitures on increase in net sales | Net sales organic |
|---|---|---|---|---|---|---|
| Q2 FY 21 | $443.3 | $76.1 | $367.2 | $599.1 | $76.4 | $522.7 |
| Q2 FY 20 | $297.7 | $— | $297.7 | $414.0 | $— | $414.0 |
| $ increase | $145.6 | $69.5 | $185.1 | $108.7 | ||
| % increase | 48.9% | 23.3% | 44.7% | 26.3% |
34
(in thousands)
| Adjusted EBITDA Reconciliation | GAAP to Non-GAAP Reconciliation For the Three Months Ended March 27, 2021 Garden | Pet | Corp | Total |
|---|---|---|---|---|
| Net income attributable to Central Garden & Pet Company | — | — | — | $72,954 |
| Interest expense, net | — | — | — | 10,151 |
| Other income | — | — | — | (704) |
| Income tax expense | — | — | — | 21,564 |
| Net income attributable to noncontrolling interest | — | — | — | 645 |
| Sum of items below operating income | — | — | — | 31,656 |
| Income (loss) from operations | $65,962 | $62,058 | $(23,410) | $104,610 |
| Depreciation & amortization | 8,804 | 8,882 | 1,168 | $18,854 |
| Adjusted EBITDA | $74,766 | $70,940 | $(22,242) | $123,464 |
(in thousands)
| Adjusted EBITDA Reconciliation | GAAP to Non-GAAP Reconciliation For the Three Months Ended March 28, 2020 Garden | Pet | Corp | Total |
|---|---|---|---|---|
| Net income attributable to Central Garden & Pet Company | — | — | — | $42,704 |
| Interest expense, net | — | — | — | 9,336 |
| Other expense | — | — | — | 979 |
| Income tax expense | — | — | — | 12,648 |
| Net income attributable to noncontrolling interest | — | — | — | 438 |
| Sum of items below operating income | — | — | — | 23,401 |
| Income (loss) from operations | $43,161 | $43,476 | $(20,532) | $66,105 |
| Depreciation & amortization | 2,595 | 9,170 | 1,411 | 13,176 |
| Adjusted EBITDA | $45,756 | $52,646 | $(19,121) | $79,281 |
(in thousands)
| Adjusted EBITDA Reconciliation | GAAP to Non-GAAP Reconciliation For the Six Months Ended March 27, 2021 Garden | Pet | Corp | Total |
|---|---|---|---|---|
| Net income attributable to Central Garden & Pet Company | — | — | — | $78,567 |
| Interest expense, net | — | — | — | 30,920 |
| Other income | — | — | — | (1.456) |
| Income tax expense | — | — | — | 22,945 |
| Net income attributable to noncontrolling interest | — | — | — | 674 |
| Sum of items below operating income | — | — | — | 53,083 |
| Income (loss) from operations | $70,613 | $105,583 | $(44,546) | $131,650 |
| Depreciation & amortization | 11,442 | 17,967 | 2,360 | 31,769 |
| Adjusted EBITDA | $82,055 | $123,550 | $(42,186) | $163,419 |
35
(in thousands)
| Adjusted EBITDA Reconciliation | GAAP to Non-GAAP Reconciliation For the Six Months Ended March 28, 2020 Garden | Pet | Corp | Total |
|---|---|---|---|---|
| Net income attributable to Central Garden & Pet Company | — | — | — | $38,287 |
| Interest expense, net | — | — | — | 17,973 |
| Other expense | — | — | — | 674 |
| Income tax expense | — | — | — | 10,920 |
| Net income attributable to noncontrolling interest | — | — | — | 316 |
| Sum of items below operating income | — | — | — | 29,883 |
| Income (loss) from operations | $36,278 | $72,213 | $(40,321) | $68,170 |
| Depreciation & amortization | 5,308 | 18,242 | 2,766 | 26,316 |
| Adjusted EBITDA | $41,586 | $90,455 | $(37,555) | $94,486 |
Inflation
Our revenues and margins are dependent on various economic factors, including rates of inflation, energy costs, consumer attitudes toward discretionary spending, currency fluctuations, and other macro-economic factors which may impact levels of consumer spending. In certain fiscal periods, we have been adversely impacted by rising input costs related to domestic inflation, particularly relating to grain and seed prices, fuel prices and the ingredients used in our garden controls and fertilizer. Rising costs in those periods have made it difficult for us to increase prices to our retail customers at a pace sufficient to enable us to maintain margins.
During fiscal 2020 and in the first six months of fiscal 2021, commodity costs as well as freight and labor costs increased. In both fiscal 2020 and the first six months of fiscal 20221, tariffs implemented had a negative impact in instances where we were unable to pass through the incremental costs.
Weather and Seasonality
Our sales of lawn and garden products are influenced by weather and climate conditions in the different markets we serve. Our Garden segment’s business is highly seasonal. In fiscal 2020, the weather during the peak gardening season was particularly favorable. In fiscal 2020, approximately 67% of our Garden segment’s net sales and 57% of our total net sales occurred during our second and third fiscal quarters. Substantially all of the Garden segment’s operating income is typically generated in this period, which has historically offset the operating loss incurred during the first fiscal quarter of the year.
Liquidity and Capital Resources
We have financed our growth through a combination of internally generated funds, bank borrowings, supplier credit, and sales of equity and debt securities to the public.
Our business is seasonal and our working capital requirements and capital resources track closely to this seasonal pattern. Generally, during the first fiscal quarter, accounts receivable reach their lowest level while inventory, accounts payable and short-term borrowings begin to increase. During the second fiscal quarter, receivables, accounts payable and short-term borrowings increase, reflecting the build-up of inventory and related payables in anticipation of the peak lawn and garden selling season. During the third fiscal quarter, inventory levels remain relatively constant while accounts receivable peak and short-term borrowings start to decline as cash collections are received during the peak selling season. During the fourth fiscal quarter, inventory levels are at their lowest, and accounts receivable and payables are substantially reduced through conversion of receivables to cash.
We service two broad markets: pet supplies and lawn and garden consumables. Our pet supplies businesses involve products that have a year round selling cycle with a slight degree of seasonality. As a result, it is not necessary to maintain large quantities of inventory to meet peak demands. Our lawn and garden businesses are highly seasonal with approximately 67% of our Garden segment’s net sales occurring during the second and third fiscal quarters. This seasonality requires the shipment of large quantities of product well ahead of the peak consumer buying periods. To encourage retailers and distributors to stock large quantities of inventory, industry practice has been for manufacturers to give extended credit terms and/or promotional discounts.
Operating Activities
Net cash used by operating activities increased by $27.5 million, from $92.7 million for the six months ended March 28, 2020, to $120.2 million for the six months ended March 27, 2021. The increase in cash used was due primarily to changes in our working capital accounts for the period ended March 27, 2021, as compared to the prior year period, primarily an increase in inventory, due to our seasonal build in preparation for the lawn and garden season and the overall increased demand for our products.
Investing Activities
Net cash used in investing activities increased $741.0 million, from $24.4 million for the six months ended March 28, 2020 to $765.4 million during the six months ended March 27, 2021. The increase in cash used in investing activities was due primarily to acquisition activity in the current year and increased capital expenditures in the current year compared to the prior year, partially offset by proceeds received from the sale of our Breeder's Choice business during the first quarter of fiscal 2021 and decreased investments in the current year compared to the prior year. During the first quarter of fiscal 2021, we acquired DoMyOwn for approximately $81 million. During the second quarter of fiscal 2021, we acquired Hopewell Nursery on December 31, 2020 for approximately $81 million and Green Garden Products on February 11, 2021 for approximately $571 million.
Financing Activities
Net cash provided by financing activities increased $319.6 million, from $49.2 million of cash used for the six months ended March 28, 2020, to $270.5 million of cash provided for the six months ended March 27, 2021. The increase in cash provided by financing activities during the current year was due primarily to the issuance of $500 million of our 2030 Notes and net borrowings under our senior secured credit facility of $190 million, partially offset by the repayment of our 2023 Notes and the corresponding premium paid on extinguishment as well as debt issuance costs incurred on the issuance of the 2030 Notes. There were also decreased open market purchases of our common stock during the current year period as compared to the prior year. During the six months ended March 27, 2021, we did not make any open market purchases of our common stock. During the six months ended March 28, 2020, we repurchased approximately 0.2 million shares of our voting common stock (CENT) on the open market at an aggregate cost of approximately $5.8 million, or approximately $26.53 per share, and 1.6 million shares of our non-voting Class A common stock (CENTA) on the open market at an aggregate cost of approximately $41.4 million, or approximately $25.89 per share.
We expect that our principal sources of funds will be cash generated from our operations and, if necessary, borrowings under our $400 million asset backed revolving credit facility. Based on our anticipated cash needs, availability under our asset backed revolving credit facility and the scheduled maturity of our debt, we believe that our sources of liquidity should be adequate to meet our working capital, capital spending and other cash needs for at least the next 12 months. However, we cannot assure you that these sources will continue to provide us with sufficient liquidity and, should we require it, that we will be able to obtain financing on terms satisfactory to us, or at all.
We believe that cash flows from operating activities, funds available under our asset backed loan facility, and arrangements with suppliers will be adequate to fund our presently anticipated working capital and capital expenditure requirements for the foreseeable future. We anticipate that our capital expenditures, which are related primarily to replacements and expansion of and upgrades to plant and equipment and also investment in our continued implementation of a scalable enterprise-wide information technology platform, will be approximately $75 million in fiscal 2021, of which we have invested approximately $34 million year to date.
As part of our growth strategy, we have acquired a number of companies in the past, and we anticipate that we will continue to evaluate potential acquisition candidates in the future. If one or more potential acquisition opportunities, including those that would be material, become available in the near future, we may require additional external capital. In addition, such acquisitions would subject us to the general risks associated with acquiring companies, particularly if the acquisitions are relatively large.
Total Debt
At March 27, 2021, our total debt outstanding was $979.0 million, as compared with $693.7 million at March 28, 2020.
Senior Notes
Issuance of $500 million 4.125% Senior Notes due 2030 and Redemption of $400 million 6.125% Senior Notes due 2023
In October 2020, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030 (the "2030 Notes"). In November 2020, we used a portion of the net proceeds to redeem all of our outstanding 6.125% senior notes due November 2023 (the "2023 Notes") at a redemption price of 101.531% plus accrued and unpaid interest, and to pay related fees and expenses, with the remainder for general corporate purposes.
We incurred approximately $8.0 million of debt issuance costs associated with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2030 Notes.
As a result of our redemption of the 2023 Notes, we incurred a call premium payment of $6.1 million, overlapping interest expense for 30 days of approximately $1.4 million and a $2.5 million non-cash charge for the write-off of unamortized deferred financing costs related to the 2023 Notes. These amounts are included in interest expense in the condensed consolidated statements of operations.
The 2030 Notes require semiannual interest payments on October 15 and April 15, commencing April 15, 2021. The 2030 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our senior secured revolving credit facility or guarantee our other debt.
We may redeem some or all of the 2030 Notes at any time, at our option, prior to October 15, 2025 at a price equal to 100% of the principal amount plus a “make-whole” premium. Prior to October 15, 2023, we may redeem up to 40% of the original aggregate principal amount of the notes with the proceeds of certain equity offerings at a redemption price of 104.125% of the principal amount of the notes. We may redeem some or all of the 2030 Notes, at our option, in whole or in part, at any time on or after October 15, 2025 for 102.063%, on or after October 15, 2026 for 101.375%, on or after October 15, 2027 for 100.688% and on or after October 15, 2028 for 100.0%, plus accrued and unpaid interest.
The holders of the 2030 Notes have the right to require us to repurchase all or a portion of the 2030 Notes at a purchase price equal to 101.0% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.
The 2030 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all financial covenants as of March 27, 2021.
$300 Million 5.125% Senior Notes due 2028
On December 14, 2017, we issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). We used the net proceeds from the offering to finance acquisitions and for general corporate purposes.
We incurred approximately $4.8 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.
The 2028 Notes require semiannual interest payments on February 1 and August 1. The 2028 Notes are unconditionally guaranteed on a senior basis by our existing and future domestic restricted subsidiaries who are borrowers under or guarantors of our senior secured revolving credit facility or who guarantee the 2030 Notes.
We may redeem some or all of the 2028 Notes at any time, at our option, prior to January 1, 2023 at the principal amount plus a “make whole” premium. We may redeem some or all of the 2028 Notes, at our option, at any time on or after January 1, 2023 for 102.563%, on or after January 1, 2024 for 101.708%, on or after January 1, 2025 for 100.854% and on or after January 1, 2026 for 100.0%, plus accrued and unpaid interest.
The holders of the 2028 Notes have the right to require us to repurchase all or a portion of the 2028 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.
The 2028 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all financial covenants as of March 27, 2021.
Issuance of $400 million 4.125% Senior Notes due 2031
In April 2021, we issued $400 million aggregate principal amount of 4.125% senior notes due April 2031 (the "2031 Notes"). The 2031 Notes require interest payments on April 30 and October 30 of each year, beginning October 30, 2021. The 2031 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our Amended Credit Facility. We used the net proceeds from the offering to repay all amounts outstanding under our Amended Credit Facility, with the remainder for general corporate purposes. We incurred debt issuance costs of approximately $6 million in conjunction with this issuance, which will be amortized over the term of the 2031 Notes.
We may redeem some or all of the 2031 Notes, at our option, at any time on or after April 30, 2026, at a redemption price of 102.063%, at any time on or after April 30, 2027 at a redemption price of 101.375%, at any time on or after April 30, 2028 at a redemption price of 100.688%, and at any time on or after April 30, 2029 at 100.000%, plus accrued and unpaid interest. We may also redeem up to 40% of the notes using the proceeds of certain equity offerings before April 30, 2024, at a redemption price equal to 104.125% of the principal amount thereof, plus accrued and unpaid interest, if any, to but excluding, the redemption date. In addition, at any time prior to April 30, 2026, we may redeem some or all of the notes at a price equal to 100% of the principal amount thereof, plus a "make-whole" premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.
The 2031 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions.
Asset-Based Loan Facility Amendment
On September 27, 2019, we entered into a Second Amended and Restated Credit Agreement (“Amended Credit Agreement”). The Amended Credit Agreement amended and restated the previous credit agreement dated April 22, 2016 and continues to provide up to a $400.0 million principal amount senior secured asset-based revolving credit facility, with up to an additional $200 million principal amount available with the consent of the Lenders, as defined, if we exercise the accordion feature set forth therein (collectively, the “Amended Credit Facility”). The Amended Credit Facility matures on September 27, 2024. We may borrow, repay and reborrow amounts under the Amended Credit Facility until its maturity date, at which time all amounts outstanding under the Credit Facility must be repaid in full.
The Amended Credit Facility is subject to a borrowing base that is calculated using a formula initially based upon eligible receivables and inventory minus certain reserves and adjustments. The Amended Credit Facility also allows us to add real property to the borrowing base so long as the real property is subject to a first priority lien in favor of the Administrative Agent for the benefit of the Lenders. Net availability under the Amended Credit Facility was $210 million as of March 27, 2021. The Amended Credit Facility includes a $50 million sublimit for the issuance of standby letters of credit and an increased $40 million sublimit for short-notice borrowings. We incurred approximately $1.6 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal expenses. The debt issuance costs are being amortized over the term of the Amended Credit Facility. As of March 27, 2021, there were borrowings of $190 million outstanding and no letters of credit outstanding under the Credit Facility. There were other letters of credit of $1.6 million outstanding as of March 27, 2021.
Borrowings under the Amended Credit Facility bear interest at an index based on LIBOR or, at our option, the Base Rate (defined as the highest of (a) the SunTrust prime rate, (b) the Federal Funds Rate plus 0.50%, (c) one-month LIBOR plus 1.00%), plus, in either case, an applicable margin based on our consolidated senior leverage ratio and (d) 0.00%. Such applicable margin for LIBOR-based borrowings fluctuates between 1.00%-1.50%, and was 1.00% as of March 27, 2021, and such applicable margin for Base Rate borrowings fluctuates between 0.00%-0.50%, and was 0.00% as of March 27, 2021. An unused line fee shall be payable monthly in respect of the total amount of the unutilized Lenders’ commitments and short-notice borrowings under the Amended Credit Facility. Letter of credit fees at the applicable margin on the average undrawn and unreimbursed amount of letters of credit shall be payable monthly and a facing fee of 0.125% shall be paid on demand for the stated amount of each letter of credit. We are also required to pay certain fees to the administrative agent under the Amended Credit Facility. As of March 27, 2021, the applicable interest rate related to Base Rate borrowings was 3.3%, and the applicable interest rate related to LIBOR-based borrowings was 1.1%.
Banks currently reporting information used to set LIBOR will stop doing so after 2021. Various parties, including government agencies, are seeking to identify an alternative rate to replace LIBOR. We are monitoring their efforts, and we will likely amend contracts to accommodate any replacement rate where it is not already provided. Our Amended Credit Facility already anticipates the potential loss of LIBOR and defines procedures for establishing a replacement rate.
In July 2017, the Financial Conduct Authority in the United Kingdom, the governing body responsible for regulating LIBOR, announced that it no longer will compel or persuade financial institutions and panel banks to make LIBOR submissions after 2021. This decision is expected to result in the end of the use of LIBOR as a reference rate for commercial loans and other indebtedness. We have both LIBOR-denominated and Euro Interbank Offer Rate (EURIBOR)-denominated indebtedness. The transition to alternatives to LIBOR could be modestly disruptive to the credit markets, and while we do not believe that the impact would be material to us, we do not yet have insight into what the impacts might be.
The Amended Credit Facility continues to contain customary covenants, including financial covenants which require us to maintain a minimum fixed charge coverage ratio of 1.00:1.00 upon triggered quarterly testing (e.g. when availability falls below certain thresholds established in the agreement), reporting requirements and events of default. The Amended Credit Facility is secured by substantially all assets of the borrowing parties. We were in compliance with all financial covenants under the Credit Facility during the period ended March 27, 2021.
Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities
In October 2020, Central (the "Parent/Issuer") issued $500 million of 2030 Notes and in November 2020, we redeemed our $400 million of 2023 Notes at price of 101.531% plus accrued and unpaid interest. In December 2017, Central issued $300 million of 2028 Notes. The 2030 Notes and 2028 Notes are fully and unconditionally guaranteed on a joint and several senior basis by each of our existing and future domestic restricted subsidiaries (the "Guarantors") which are borrowers under or guarantors of our senior secured revolving credit facility ("Credit Facility"). The 2030 Notes and 2028 Notes are unsecured senior obligations and are subordinated to all of our existing and future secured debt, including our Credit Facility, to the extent of the value of the collateral securing such indebtedness. There are no significant restrictions on the ability of the Guarantors to make distributions to the Parent/Issuer. Certain subsidiaries and operating divisions of the Company do not guarantee the 2030 or 2028 Notes and are referred to as the Non-Guarantors.
The Guarantors jointly and severally, and fully and unconditionally, guarantee the payment of the principal and premium, if any, and interest on the 2030 and 2028 Notes when due, whether at stated maturity of the 2030 and 2028 Notes, by acceleration, call for redemption or otherwise, and all other obligations of the Company to the holders of the 2030 and 2028 Notes and to the trustee under the indenture governing the 2030 and 2028 Notes (the "Guarantee"). The Guarantees are senior unsecured obligations of each Guarantor and are of equal rank with all other existing and future senior indebtedness of the Guarantors.
The obligations of each Guarantor under its Guarantee shall be limited to the maximum amount as will, after giving effect to all other contingent and fixed liabilities of such Guarantor and to any collections from or payments made by or on behalf of any other Guarantor in respect of the obligations of such Guarantor under the guarantee not constituting a fraudulent conveyance or fraudulent transfer under Federal or state law.
The Guarantee of a Guarantor will be released:
(1) upon any sale or other disposition of all or substantially all of the assets of that Guarantor (including by way of merger or consolidation), in accordance with the governing indentures, to any person other than the Company;
(2) if such Guarantor merges with and into the Company, with the Company surviving such merger;
(3) if the Guarantor is designated as an Unrestricted Subsidiary; or
(4) if the Company exercises its legal defeasance option or covenant defeasance option or the discharge of the Company's obligations under the indentures in accordance with the terms of the indentures.
The following tables present summarized financial information of the Parent/Issuer subsidiaries and the Guarantor subsidiaries. All intercompany balances and transactions between subsidiaries under Parent/Issuer and subsidiaries under the Guarantor have been eliminated. The information presented below excludes eliminations necessary to arrive at the information on a consolidated basis. In presenting the summarized financial statements, the equity method of accounting has been applied to the Parent/Issuer's interests in the Guarantor Subsidiaries. The summarized information excludes financial information of the Non-Guarantors, including earnings from and investments in these entities.
(in thousands)
| Summarized Statements of Operations | Six Months Ended March 27, 2021 Parent/Issuer | Guarantors | Fiscal Year Ended September 26, 2020 Parent/Issuer | Guarantors |
|---|---|---|---|---|
| Net sales | $459,381 | $975,121 | $839,425 | $1,720,279 |
| Gross profit | $105,803 | $311,689 | $195,893 | $555,616 |
| Income (loss) from operations | $6,638 | $129,966 | $2,724 | $187,114 |
| Equity in earnings of Guarantor subsidiaries | $101,530 | $— | $148,349 | $— |
| Net income (loss) | $(18,993) | $101,530 | $(33,326) | $148,349 |
Summarized Balance Sheet Information
(in thousands)
| As of March 27, 2021 Parent/Issuer | Guarantors | As of September 26, 2020 Parent/Issuer | Guarantors | |
|---|---|---|---|---|
| Current assets | $341,034 | $764,246 | $900,416 | $560,919 |
| Intercompany receivable from Non-guarantor subsidiaries | 688,458 | 61,391 | 36,329 | 61,595 |
| Other assets | 2,248,493 | 1,647,149 | 2,042,206 | 1,631,167 |
| Total assets | $3,277,985 | $2,472,786 | $2,978,951 | $2,253,681 |
| Current liabilities | $169,264 | $278,360 | $170,378 | $247,810 |
| Long-term debt | 978,887 | — | 693,956 | — |
| Other liabilities | 1,020,008 | 103,420 | 1,095,288 | 101,912 |
| Total liabilities | $2,168,159 | $381,780 | $1,959,622 | $349,722 |
40
Off-Balance Sheet Arrangements
There have been no material changes to the information provided in our Annual Report on Form 10-K for the fiscal year ended September 26, 2020 regarding off-balance sheet arrangements.
Contractual Obligations
Except as discussed in Note 8. Long Term Debt, related to our issuance of the 2030 Notes and the 2031 Notes and redemption of 2023 Notes, there have been no material changes outside the ordinary course of business in our contractual obligations set forth in the Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources in our Annual Report on Form 10-K for the fiscal year ended September 26, 2020.
New Accounting Pronouncements
Refer to Footnote 1 in the notes to the condensed consolidated financial statements for new accounting pronouncements.
Critical Accounting Policies, Estimates and Judgments
There have been no material changes to our critical accounting policies, estimates and assumptions or the judgments affecting the application of those accounting policies since our Annual Report on Form 10-K for the fiscal year ended September 26, 2020.
Market risk
As filed, 164 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There has been no material change in our exposure to market risk from that discussed in our Annual Report on Form 10-K for the fiscal year ended September 26, 2020.
Controls and procedures
As filed, 1,890 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) Evaluation of Disclosure Controls and Procedures. Our Chief Executive Officer and principal financial officer have reviewed, as of the end of the period covered by this report, the “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) that ensure that information relating to the Company required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported in a timely and proper manner and that such information is accumulated and communicated to our management, including our Chief Executive Officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based upon this review, such officers concluded that our disclosure controls and procedures were effective as of March 27, 2021.
(b) Changes in Internal Control Over Financial Reporting. During December 2020 through February 2021, we completed the acquisitions of DoMyOwn, Hopewell Nursery and Green Garden Products. Under guidelines established by the SEC, companies are permitted to exclude acquisitions from their assessment of internal control over financial reporting during the first year of an acquisition while integrating the acquired company. In conducting our evaluation of the effectiveness of our internal control over financial reporting, we excluded the three recent acquisitions from our evaluation for the period ended March 27, 2021. We are in the process of integrating the three acquisitions into our system of internal control over financial reporting.
Except as noted above, there were no other changes in our internal control over financial reporting during the second quarter of fiscal 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 162 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year ended September 26, 2020.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-27. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-12-27 to 2021-03-27 | $935.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2020-09-27 to 2021-03-27 | $1.53bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-12-27 to 2021-03-27 | $662.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2020-09-27 to 2021-03-27 | $1.09bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-12-27 to 2021-03-27 | $272.4m | us-gaap:GrossProfit |
| Gross profit | 6 months2020-09-27 to 2021-03-27 | $437.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2020-12-27 to 2021-03-27 | $167.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2020-09-27 to 2021-03-27 | $306.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-12-27 to 2021-03-27 | $104.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2020-09-27 to 2021-03-27 | $131.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-12-27 to 2021-03-27 | $10.2m | us-gaap:InterestExpense |
| Interest expense | 6 months2020-09-27 to 2021-03-27 | $31.2m | us-gaap:InterestExpense |
| Income tax | 3 months2020-12-27 to 2021-03-27 | $21.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-09-27 to 2021-03-27 | $22.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-12-27 to 2021-03-27 | $73.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-09-27 to 2021-03-27 | $78.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-12-27 to 2021-03-27 | $1.32 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2020-09-27 to 2021-03-27 | $1.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-12-27 to 2021-03-27 | $1.35 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2020-09-27 to 2021-03-27 | $1.46 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-12-27 to 2021-03-27 | 55,156,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2020-09-27 to 2021-03-27 | 54,930,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2020-09-27 to 2021-03-27 | −$120.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2020-09-27 to 2021-03-27 | $33.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2020-09-27 to 2021-03-27 | $4.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-03-27 | $39.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-27 | $1.41bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-27 | $2.85bn | us-gaap:Assets |
| Current liabilities | At period end2021-03-27 | $536.8m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2021-03-27 | $978.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-03-27 | $91.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2021-03-27 | $1.16bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000887733-21-000007. Last ingested by Listed: Nov 10, 2026, 04:49 ET. Listed shows no prices and gives no investment advice.